Skip to main content

Research Repository

Advanced Search

Costs and effects of screening and treating low risk women with a singleton pregnancy for asymptomatic bacteriuria, the ASB study

Kazemier, Brenda M; Schneeberger, Caroline; De Miranda, Esteriek; Van Wassenaer, Aleid; Bossuyt, Patrick M; Vogelvang, Tatjana E; Reijnders, Frans J L; Delemarre, Friso M C; Verhoeven, Corine J M; Oudijk, Martijn A; Van Der Ven, Jeanine A; Kuiper, Petra N; Feiertag, Nicolette; Ott, Alewijn; De Groot, Christianne J M; Mol, Ben Willem J; Geerlings, Suzanne E

Costs and effects of screening and treating low risk women with a singleton pregnancy for asymptomatic bacteriuria, the ASB study Thumbnail


Authors

Brenda M Kazemier

Caroline Schneeberger

Esteriek De Miranda

Aleid Van Wassenaer

Patrick M Bossuyt

Tatjana E Vogelvang

Frans J L Reijnders

Friso M C Delemarre

Martijn A Oudijk

Jeanine A Van Der Ven

Petra N Kuiper

Nicolette Feiertag

Alewijn Ott

Christianne J M De Groot

Ben Willem J Mol

Suzanne E Geerlings



Abstract

Background
The prevalence of asymptomatic bacteriuria (ASB) in pregnancy is 2-10% and is associated with both maternal and neonatal adverse outcomes as pyelonephritis and preterm delivery. Antibiotic treatment is reported to decrease these adverse outcomes although the existing evidence is of poor quality.

Methods/Design
We plan a combined screen and treat study in women with a singleton pregnancy. We will screen women between 16 and 22 weeks of gestation for ASB using the urine dipslide technique. The dipslide is considered positive when colony concentration ≥105 colony forming units (CFU)/mL of a single microorganism or two different colonies but one ≥105 CFU/mL is found, or when Group B Streptococcus bacteriuria is found in any colony concentration. Women with a positive dipslide will be randomly allocated to receive nitrofurantoin or placebo 100 mg twice a day for 5 consecutive days (double blind). Primary outcomes of this trial are maternal pyelonephritis and/or preterm delivery before 34 weeks. Secondary outcomes are neonatal and maternal morbidity, neonatal weight, time to delivery, preterm delivery rate before 32 and 37 weeks, days of admission in neonatal intensive care unit, maternal admission days and costs.

Discussion
This trial will provide evidence for the benefit and cost-effectiveness of dipslide screening for ASB among low risk women at 16–22 weeks of pregnancy and subsequent nitrofurantoin treatment.

Trial registration
Dutch trial registry: NTR-3068

Journal Article Type Article
Acceptance Date Jun 21, 2012
Online Publication Date Jun 21, 2012
Publication Date 2012
Deposit Date Aug 31, 2023
Publicly Available Date Sep 1, 2023
Journal BMC Pregnancy and Childbirth
Publisher Springer Verlag
Peer Reviewed Peer Reviewed
Volume 12
Article Number 52
DOI https://doi.org/10.1186/1471-2393-12-52
Public URL https://nottingham-repository.worktribe.com/output/23513731
Publisher URL https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/1471-2393-12-52

Files





You might also like



Downloadable Citations